In AMD, oxidative stress and visual cycle byproducts trigger RPE and choroidal cells to downregulate complement inhibitors such as decay-accelerating factor (DAF), membrane cofactor protein (MCP), and CD59, enabling pathological complement activation in host tissues [53]. Here, CD46 is linked to age-related macular degeneration.